OA01363A - Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques. - Google Patents

Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques.

Info

Publication number
OA01363A
OA01363A OA51809A OA51809A OA01363A OA 01363 A OA01363 A OA 01363A OA 51809 A OA51809 A OA 51809A OA 51809 A OA51809 A OA 51809A OA 01363 A OA01363 A OA 01363A
Authority
OA
OAPI
Prior art keywords
diphenyl
preparation
methane derivatives
derivatives bearing
basic substituents
Prior art date
Application number
OA51809A
Other languages
English (en)
French (fr)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of OA01363A publication Critical patent/OA01363A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA51809A 1958-05-07 1964-12-31 Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques. OA01363A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF25702A DE1111642B (de) 1958-05-07 1958-05-07 Verfahren zur Herstellung von basisch substituierten Diphenylmethan-Derivaten mit Herz- und Kreislaufwirksamkeit

Publications (1)

Publication Number Publication Date
OA01363A true OA01363A (fr) 1969-07-04

Family

ID=7091732

Family Applications (1)

Application Number Title Priority Date Filing Date
OA51809A OA01363A (fr) 1958-05-07 1964-12-31 Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques.

Country Status (10)

Country Link
US (1) US3152173A (fi)
BE (1) BE578515A (fi)
CH (8) CH388333A (fi)
CY (1) CY277A (fi)
DE (1) DE1111642B (fi)
FR (1) FR553M (fi)
GB (1) GB916644A (fi)
MY (1) MY6400049A (fi)
NL (2) NL108640C (fi)
OA (1) OA01363A (fi)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3262977A (en) * 1962-03-10 1966-07-26 Chinoin Gyogyszer Es Vegyeszet N-aralkyl-1, 1-diphenyl-propylamine derivatives
NL296693A (fi) * 1962-08-16
FR95908E (fr) * 1963-11-09 1972-01-31 Degussa Procédé de préparation de nouvelles aminocétones et des alcools secondaires correspondants.
US3457354A (en) * 1965-09-21 1969-07-22 Merck & Co Inc Treatment of hypertension with 2-hydroxy (or amino) - 4,5 - dihydroxyphenethylamine derivatives
US3895057A (en) * 1967-10-13 1975-07-15 Dainippon Pharmaceutical Co Aminoalkanols and their pharmaceutically acceptable acid-addition salts, and production thereof
US4329367A (en) * 1974-08-05 1982-05-11 Ciba-Geigy Corporation 1-(Aralkoxyphenyl)-2-(bis-arylalkylamino)-alkanes
DE2902172C2 (de) * 1979-01-20 1984-05-10 UOP Inc., 60016 Des Plaines, Ill. Verfahren zur Herstellung eines N,N'-Dialkylphenylendiamins
JPS59500764A (ja) * 1982-04-23 1984-05-04 カオラ　コズメテイカイ　エス　ハズタルタスベジパリ　バララト プレニルアミン含有化粧品組成物
ATE41655T1 (de) * 1985-04-16 1989-04-15 Hoffmann La Roche Phenaethanolaminderivate.
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
RS50406B (sr) * 2001-01-26 2009-12-31 Schering Corporation, Upotreba supstituisanih jedinjenja azetidinona za lečenje sitosterolemije
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
HUP0303917A2 (hu) * 2001-01-26 2004-03-01 Schering Corporation Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
US20020183305A1 (en) * 2001-01-26 2002-12-05 Schering Corporation Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
DE60221798T2 (de) * 2001-01-26 2008-06-05 Schering Corp. Kombinationen von gallensäure sequestriermitteln und hemmern der sterol absorption zur behandlung von kardiovaskulären indikationen
BR0206654A (pt) * 2001-01-26 2004-02-25 Schering Corp Combinações de ativador(es) de receptor ativado por proliferação de peroxisoma (ppar) e inibidor(es) de absorção de esterol e tratamentos para indicações vasculares
PL369033A1 (en) * 2001-01-26 2005-04-18 Schering Corporation Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
AR038956A1 (es) * 2001-05-25 2005-02-02 Schering Corp Uso de un compuesto que regula la produccion o niveles de peptidos beta amiloides para la manufactura de un medicamento para tratar la enfermedad de alzheimer y/o para regular dichos niveles de peptidos amiloides beta en un sujeto
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
ES2312624T3 (es) * 2001-09-21 2009-03-01 Schering Corporation Metodos para tratar o prevenir la inflamacion vascular usando un inhibidor (inhibidores) de la absorcion de esterol.
DE60216300T2 (de) * 2001-09-21 2007-06-28 Schering Corp. Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption
EP1545519B1 (en) 2002-08-19 2011-03-23 Pfizer Inc. Combination therapy for hyperproliferative diseases
JP2006508189A (ja) * 2002-11-06 2006-03-09 シェーリング　コーポレイション 自己免疫障害の処置のためのコレステロール吸収インヒビター
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7235543B2 (en) 2003-03-07 2007-06-26 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
EP1606287B1 (en) * 2003-03-07 2013-10-02 Merck Sharp & Dohme Corp. Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
DE602004018617D1 (de) 2003-03-07 2009-02-05 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
JP2007510659A (ja) * 2003-11-05 2007-04-26 シェーリング　コーポレイション 脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置
US20060147520A1 (en) * 2004-07-26 2006-07-06 Curtis Ruegg Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
ATE551059T1 (de) 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
EP3911648A4 (en) 2019-01-18 2022-10-26 Astrazeneca AB PCSK9 INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2601323A (en) * 1949-02-02 1952-06-24 Upjohn Co Process for preparing 4, 4-diphenyl-6-dimethylamino-heptanone-3
US2681934A (en) * 1950-01-06 1954-06-22 Commercial Solvents Corp Substituted diphenylalkylamines
US2797242A (en) * 1953-08-11 1957-06-25 Parke Davis & Co Substituted alpha-benzylphenethylamines and methods for producing the same
US2738347A (en) * 1954-12-13 1956-03-13 Olin Mathieson Penicillin salt of benzhydryl-phenethylamine
US2872374A (en) * 1955-02-02 1959-02-03 Nat Drug Co Muscle-relaxing tranquilizer compositions
US2894033A (en) * 1955-11-15 1959-07-07 Nl Combinatie Chem Ind Antispasmodic 1, 1-diphenyl-3-dialkylaminopropane, and its tertiary and quaternary salts
US2854379A (en) * 1956-06-06 1958-09-30 Miles Lab Tranquilizing composition comprising 2-ethyl-cis-crotonylurea
DE1058063B (de) * 1957-02-08 1959-05-27 Hoechst Ag Verfahren zur Herstellung von analgetisch wirksamen substituierten Phenylaethylaminen

Also Published As

Publication number Publication date
DE1111642B (de) 1961-07-27
GB916644A (en) 1963-01-23
CH388329A (de) 1965-02-28
CY277A (en) 1964-02-12
FR553M (fi) 1961-05-29
MY6400049A (en) 1964-12-31
CH388328A (de) 1965-02-28
CH396931A (de) 1965-08-15
NL238796A (fi)
NL108640C (fi)
US3152173A (en) 1964-10-06
BE578515A (fi)
CH388334A (de) 1965-02-28
CH388332A (de) 1965-02-28
CH388333A (de) 1965-02-28
CH385878A (de) 1964-12-31
CH397710A (de) 1965-08-31

Similar Documents

Publication Publication Date Title
OA01363A (fr) Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques.
FR1229384A (fr) Procédé de préparation de dérivés de la 2, 3-dimercapto-quinoxaline
BE589982A (fr) Procédé de préparation de dérivés de la phtalimidine.
BE591486A (fr) Procédé pour la préparation de dérivés de 5-fluoro-cytosine.
BE579237A (fr) Procédé de préparation des phosphoramidates.
FR1292922A (fr) Procédé de préparation de dérivés de diphényl-méthane portant des substituants basiques
FR1309818A (fr) Procédé de préparation de dérivés de 20-alcoyl-amino-stéroïdes
BE583839A (fr) Procédé de préparation de dérivés quinoniques.
FR1238739A (fr) Procédé de préparation de dérivés hydrosolubles de testostérone
FR1481001A (fr) Procédé de préparation des dérivés de la phénacyl-pipérazine
FR1274397A (fr) Procédé de préparation de dérivés 9alpha-fluoro 16alpha-méthyl delta1, 4-pregnadiènes
BE589345A (fr) Procédé de préparation de dérivés phénothiaziniques.
FR1274399A (fr) Procédé perfectionné de préparation de dérivés du 5-nitro-2-formyl-furan
FR1223732A (fr) Procédé de préparation de dérivés 2-thiono-4-hydroxytétrahydropyrimidines
BE577308A (fr) Procédé de préparation de dérivés du thiaxanthène à substituants basiques.
FR1295307A (fr) Procédé de préparation de dérivés cyclopentano-phénanthréniques
FR1404860A (fr) Procédé de préparation de dérivés de la 5-amino-8-hydroxy-1. 4-naphtoquinone-1-imine portant des substituants basiques
FR1294102A (fr) Procédé de préparation des dérivés azotés de phénylalcanols
FR1330109A (fr) Procédé de préparation de dérivés de la dichloro-acétanilide
FR1383702A (fr) Procédé de préparation de dérivés de la disulfamylaniline
CH384582A (fr) Procédé de préparation de dérivés de la dihydrobenzothiadiazine
FR1291508A (fr) Procédé de préparation de dérivés de la dihydro-vitamine k
FR1272913A (fr) Procédé de préparation des 5-alkyl-2-p-halogénobenzènesulfonamido-1, 3, 4-thiadiazoles
FR1298304A (fr) Procédé de préparation de dérivés de la kanamycine
FR1341467A (fr) Procédé de préparation de dérivés de nu-carboxylalcoyl-2-phényléthylamines